rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1993-8-26
|
pubmed:abstractText |
The prognosis of patients with multifocal primary and early or multiple relapsed Ewing's sarcoma is poor with conventional chemoradiotherapy and surgery. We evaluated the efficacy and feasibility of a myeloablative regimen administered as consolidation treatment for these patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1482-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8101562-Adolescent,
pubmed-meshheading:8101562-Adult,
pubmed-meshheading:8101562-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8101562-Bone Neoplasms,
pubmed-meshheading:8101562-Carboplatin,
pubmed-meshheading:8101562-Child,
pubmed-meshheading:8101562-Cohort Studies,
pubmed-meshheading:8101562-Combined Modality Therapy,
pubmed-meshheading:8101562-Cytokines,
pubmed-meshheading:8101562-Etoposide,
pubmed-meshheading:8101562-Feasibility Studies,
pubmed-meshheading:8101562-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8101562-Humans,
pubmed-meshheading:8101562-Melphalan,
pubmed-meshheading:8101562-Prognosis,
pubmed-meshheading:8101562-Recurrence,
pubmed-meshheading:8101562-Remission Induction,
pubmed-meshheading:8101562-Sarcoma, Ewing,
pubmed-meshheading:8101562-Survival Analysis,
pubmed-meshheading:8101562-Whole-Body Irradiation
|
pubmed:year |
1993
|
pubmed:articleTitle |
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
|
pubmed:affiliation |
Department of Pediatric Hematology/Oncology, Heinrich Heine Universität, Düsseldorf, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|